OBJECTIVES: To explore the role of Oct3/4, Nanog and Sox2 in regeneration of rat tracheal epithelium. MATERIALS AND METHODS: An ex vivo model of rat tracheal epithelial regeneration using 5-fluorouracil (5-FU) was developed, to induce injury. Expression levels of Oct3/4, Nanog and Sox2 were examined using Western blot analysis, RT-PCR or microscopically observed immunofluorescence, and cell morphological changes were observed using HE staining, during the recovery process. RESULTS: Oct3/4, Nanog and Sox2 were not detectable in normal tracheal epithelium. After treatment with 5-FU, the normally proliferating tracheal epithelium desquamated and only a few cells in G0 phase of the cell cycle were left on the basement membrane and Oct3/4, Nanog and Sox2 could be observed at this time. Thereafter, the number of Oct3/4-, Nanog- and Sox2-positive cells increased gradually. When the cells differentiated into ciliate cells, mucous cells or basal cells, and restored pseudostratified mucociliary epithelium, the number of Oct3/4-, Nanog- and Sox2-positive cells decreased and gradually disappeared. CONCLUSIONS: G0 phase cells with resistance to 5-FU damage expressed Oct3/4, Nanog and Sox2. This indicated that these cells were undifferentiated, but had the ability to terminally differentiate into downstream-type cells. They possessed stem cell properties. The results are consistent with Oct3/4, Nanog and Sox2-expressing cells being considered as tracheal stem cells.
OBJECTIVES: To explore the role of Oct3/4, Nanog and Sox2 in regeneration of rat tracheal epithelium. MATERIALS AND METHODS: An ex vivo model of rat tracheal epithelial regeneration using 5-fluorouracil (5-FU) was developed, to induce injury. Expression levels of Oct3/4, Nanog and Sox2 were examined using Western blot analysis, RT-PCR or microscopically observed immunofluorescence, and cell morphological changes were observed using HE staining, during the recovery process. RESULTS:Oct3/4, Nanog and Sox2 were not detectable in normal tracheal epithelium. After treatment with 5-FU, the normally proliferating tracheal epithelium desquamated and only a few cells in G0 phase of the cell cycle were left on the basement membrane and Oct3/4, Nanog and Sox2 could be observed at this time. Thereafter, the number of Oct3/4-, Nanog- and Sox2-positive cells increased gradually. When the cells differentiated into ciliate cells, mucous cells or basal cells, and restored pseudostratified mucociliary epithelium, the number of Oct3/4-, Nanog- and Sox2-positive cells decreased and gradually disappeared. CONCLUSIONS: G0 phase cells with resistance to 5-FU damage expressed Oct3/4, Nanog and Sox2. This indicated that these cells were undifferentiated, but had the ability to terminally differentiate into downstream-type cells. They possessed stem cell properties. The results are consistent with Oct3/4, Nanog and Sox2-expressing cells being considered as tracheal stem cells.
Authors: Jianlong Wang; Sridhar Rao; Jianlin Chu; Xiaohua Shen; Dana N Levasseur; Thorold W Theunissen; Stuart H Orkin Journal: Nature Date: 2006-11-08 Impact factor: 49.962
Authors: Min Kim; Heth Turnquist; John Jackson; Magda Sgagias; Ying Yan; Maokai Gong; Michael Dean; John G Sharp; Kenneth Cowan Journal: Clin Cancer Res Date: 2002-01 Impact factor: 12.531
Authors: O V Paiushina; E I Damaratskaia; E I Bueverova; T M Nikonova; N N Butorina; E A Molchanova; V I Starostin Journal: Izv Akad Nauk Ser Biol Date: 2006 Nov-Dec
Authors: Mark J Kiel; Shenghui He; Rina Ashkenazi; Sara N Gentry; Monica Teta; Jake A Kushner; Trachette L Jackson; Sean J Morrison Journal: Nature Date: 2007-08-29 Impact factor: 49.962
Authors: Ariel A Avilion; Silvia K Nicolis; Larysa H Pevny; Lidia Perez; Nigel Vivian; Robin Lovell-Badge Journal: Genes Dev Date: 2003-01-01 Impact factor: 11.361
Authors: M C Barsotti; A Magera; C Armani; F Chiellini; F Felice; D Dinucci; A M Piras; A Minnocci; R Solaro; G Soldani; A Balbarini; R Di Stefano Journal: Cell Prolif Date: 2011-02 Impact factor: 6.831